Welcome to CDC stacks | Seasonal Influenza A (H1N1) Infection in Early Pregnancy and Second Trimester Fetal Demise - 18196 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Seasonal Influenza A (H1N1) Infection in Early Pregnancy and Second Trimester Fetal Demise
  • Published Date:
    Jan 2011
  • Source:
    Emerg Infect Dis. 17(1):107-109.
Filetype[PDF-321.04 KB]


Details:
No Related Documents.
You May Also Like:
  1. Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the Vaccine Adverse Event Reporting System, July, 2010 – May, 2016
    Personal Author:
    Moro, Pedro; Baumblatt, Jane; Lewis, Paige; Cragan, Janet; Tepper, Naomi; Cano, Maria;
    Published:
    February 2017
    Source:
    Drug Saf. 40(2):145-152
    Description:
    Introduction: : Routine immunization of pregnant women with seasonal inactivated influenza vaccines (IIV) is recommended in all trimesters of pregnancy. A review of the Vaccine Adverse Event Reporting System (VAERS) during 1990–2009 did not find an...
    File Type:
    Filetype[PDF - 387.00 KB]
  2. Respiratory Illness Hospitalizations Among Pregnant Women During Influenza Season, 1998–2008
    Personal Author:
    Martin, Angela; Cox, Shanna; Jamieson, Denise J.; Whiteman, Maura K.; Kulkarni, Aniket; Tepper, Naomi K.;
    Published:
    Sep 2013
    Source:
    Matern Child Health J. 17(7):1325-1331
    Description:
    To examine health care burden, pregnancy outcomes and impact of high risk medical conditions among pregnancy hospitalizations during influenza season. Length of stay, hospitalization charges, and delivery complications were compared between hospitali...
    File Type:
    Filetype[PDF - 72.93 KB]
  3. Adverse Events following Administration to Pregnant Women of Influenza A (H1N1) 2009 Monovalent Vaccine reported to the Vaccine Adverse Event Reporting System (VAERS).
    Personal Author:
    MORO, Pedro L.; BRODER, Karen; ZHETEYEVA, Yenlik; REVZINA, Natalya; TEPPER, Naomi; KISSIN, Dmitry; BARASH, Faith; ARANA, Jorge; BRANTLEY, Mary D.; DING, Helen; SINGLETON, James A.; WALTON, Kimp; HABER, Penina; LEWIS, Paige; YUE, Xin; DESTEFANO, Frank; VELLOZZI, Claudia;
    Published:
    June 21 2011
    Source:
    Am J Obstet Gynecol. 205(5):473.e1-473.e9
    Description:
    Objective: : To evaluate and summarize reports to the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting system, in pregnant women who received Influenza A (H1N1) 2009 Monovalent Vaccine to assess for potential vaccine safety pro...
    File Type:
    Filetype[PDF - 188.28 KB]
  4. Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy
    Personal Author:
    Wheeler, Sarahn M.; Dotters-Katz, Sarah; Heine, R. Phillip; Grotegut, Chad A.; Swamy, Geeta K.;
    Published:
    Nov 2015
    Source:
    Emerg Infect Dis. 21(11):1951-1955
    Description:
    Given the illness and deaths caused by respiratory syncytial virus (RSV) infection during the first year of life, preventing infant RSV infections through maternal vaccination is intriguing. However, little is known about the extent and maternal effe...
    File Type:
    Filetype[PDF - 1.66 MB]
  5. Chorioamnionitis Following Vaccination in the Vaccine Adverse Event Reporting System
    Personal Author:
    Datwani, Hema; Moro, Pedro L.; Harrington, Theresa; Broder, Karen;
    Published:
    May 11 2015
    Source:
    Vaccine. 33(27):3110-3113
    Description:
    Background: : In October 2012, the Advisory Committee on Immunization Practices (ACIP) recommended a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) during each pregnancy, irrespective of the patient’s prior histor...
    File Type:
    Filetype[PDF - 301.62 KB]